RecruitingNot ApplicableNCT06519812

Endoscopic Combined Intrarenal Surgery vs. Percutaneous Nephrolithotomy for Treatment of Staghorn Calculi

Efficacy and Safety of Endoscopic Combined Intrarenal Surgery vs. Percutaneous Nephrolithotomy for Treatment of Staghorn Calculi, A Prospective Randomized Study

Sponsor

Al-Azhar University

Enrollment

100 participants

Start Date

Jul 1, 2023

Study Type

INTERVENTIONAL

Conditions

Urinary Calculi

Summary

This is a prospective randomized study to compare endoscopic combined intrarenal surgery and PCNL as modalities of treatment for staghorn stones. In terms of efficacy and safety

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria2

Patients are more than 18 and less than 65 years old.
Patients with renal staghorn stones based on imaging modalities (stones occupying the renal pelvis and extending into at least 2 major calyces).

Exclusion Criteria7

Patients with renal insufficiency (serum creatinine \> 1.6 mg/dl)
patients with active urinary tract infection.
Patients with congenital renal anomalies.
Morbid obesity (BMI \> 35 kg/m2).
Pregnancy.
Bleeding Coagulopathy.
Skeletal deformity

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURECombined Intrarenal Surgery and percutaneous nephrolithotomy

A study was conducted to compare endoscopic combined intrarenal surgery and percutaneous nephrolithotomy as modalities of treatment for staghorn stones.